Where X and Y Meet

I am frequently asked at what level of activity a practice will be profitable. Bruce Sanders, Executive Director of the ACP and I had this conversation at the AVF just recently. While this is a bit of a loaded question… Read More

Documentation Scrutiny Comes With New Technology

With the advent of new treatment options being approved by the FDA, practices are finding their documentation under more scrutiny than previously experienced. This has caused some unforeseen and sometimes surprising results. When sending claims for an unlisted procedure code… Read More

Experiences With Varithena

Recent experiences with Varithena claims have produced results we felt would be interesting to the venous community, so we thought we would share. As noted in a previous article by AJ Riviezzo, the claims have paid with some inconsistencies. We… Read More

Medicaid as a Payer?

With the cuts in reimbursement, increasing preauthorization requirements, and various government hoops to jump through; do you really want another payer with ‘hoops’ and poor reimbursement? The answer is a definite maybe. If your practice is already experiencing a wait… Read More

New Year, New Cards

Happy New Year! The purpose of this article is to bring attention to the “new year, new insurance question.” Though not all, a lot of insurance plans renew at the beginning of the year. Now is a good time to… Read More

2015 Payer Guideline Changes

2015 brings some significant changes to payer guidelines. While you should be checking these regularly throughout the year, the new year is a good time to really go over them and address how they affect your practice. With the advent… Read More

The Charting Rules of Diagnostic Radiology

Good charting is becoming a significant requirement and not a luxury. Your ultrasound reports are often the decider between a paid claim and a continued denial. There are some great resources out there on charting for diagnostic radiology, which this… Read More

Initial Varithena Payment Results

Not surprisingly, we have a number of clients that have treated some patients using the new Varithena Polidocanol injection program. We also have several more interested in both the clinical feedback and the financial feedback. Based on a number of… Read More

Biometrics and Medicare

One element of the Affordable Care Act (Section 640) is to allow CMS to conduct ‘enhanced enrollment screening’. In short, any provider or a ‘5% or more owner of a company’ that is considered a high level of risk may… Read More